INQUIRY REGARDING WHO PRODUCT-SPECIFIC GUIDANCE ON THE DESIGN OF BIOEQUIVALENCE STUDIES.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 62
- Publication type:
- Article
Works matching IS 10109609 AND DT 2021 AND VI 35 AND IP 1
Results: 9
1
2
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 93
- Publication type:
- Article
3
GOOD MANUFACTURING PRACTICES FOR MEDICAL GASES.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 70
- Publication type:
- Article
4
GUIDANCE ON SETTING REMAINING SHELF LIFE FOR THE SUPPLY AND PROCUREMENT OF EMERGENCY HEALTH KITS.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 57
- Publication type:
- Article
5
GELATIN (GELATINA).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 48
- Publication type:
- Article
6
ETHANOL, ANHYDROUS (ETHANOLUM, ANHYDRICUM).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 38
- Publication type:
- Article
7
WHO Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce: Update for improving reliance and adaptation to the new pharmaceutical environment.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 8
- By:
- Publication type:
- Article
8
55<sup>th</sup> Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) meeting.
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 2
- Publication type:
- Article
9
ETHANOL 96% (V/V) (ETHANOLUM 96% (V/V)).
- Published in:
- WHO Drug Information, 2021, v. 35, n. 1, p. 30
- Publication type:
- Article